Role of NOD2 variants in spondylarthritis

Arthritis and Rheumatism

Volumn 46, Issue 6, 2002, Pages 1629-1633

  Crane, Alison M ^a   Bradbury, Linda ^a   Van Heel, David A ^a   McGovern, Dermot P B ^a   Brophy, Sinead ^b   Rubin, Laurence ^c   Siminovitch, Katherine A ^d   Wordsworth, B Paul ^a   Calin, Andrei ^b   Brown, Matthew A ^a  

^a UNIVERSITY OF OXFORD   (United Kingdom)

^b ROYAL NATIONAL HOSPITAL FOR RHEUMATIC DISEASES   (United Kingdom)

^c ST MICHAEL'S HOSPITAL   (Canada)

^d UNIVERSITY OF TORONTO   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ARGININE; GLYCINE; LEUCINE; PROLINE; SERINE; TRYPTOPHAN;

ADULT; ANKYLOSING SPONDYLITIS; ARTICLE; CHROMOSOME 16; CHROMOSOME MAP; CLINICAL FEATURE; COLITIS; CONTROLLED STUDY; CROHN DISEASE; DISEASE ACTIVITY; DISEASE ASSOCIATION; ENTERITIS; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; HUMAN; MAJOR CLINICAL STUDY; ONSET AGE; PRIORITY JOURNAL; QUESTIONNAIRE; ULCERATIVE COLITIS;

ADULT; AGE OF ONSET; CARRIER PROTEINS; CASE-CONTROL STUDIES; COHORT STUDIES; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; LOD SCORE; NOD2 SIGNALING ADAPTOR PROTEIN; POLYMORPHISM, SINGLE NUCLEOTIDE; PROTEINS; RISK FACTORS; SPONDYLARTHRITIS;

EID: 0036273466     PISSN: 00043591     EISSN: None     Source Type: Journal    
DOI: 10.1002/art.10329     Document Type: Article

References (20)

1. Spondyloarthropathy is underestimated in inflammatory bowel disease: Prevalence and HLA association
2. Enteropathic spondylarthritis in chronic inflammatory bowel diseases: Prevalence, manifestation pattern and HLA association
3. The evolution of spondyloarthropathies in relation to gut histology. III. Relation between gut and joint
4. The evolution of spondyloarthropathies in relation to gut histology. I. Clinical aspects
5. Association of NOD2 leucine-rich repeat variants with susceptibility to Crohn's disease
6. A frameshift mutation in NOD2 associated with susceptibility to Crohn's disease
7. Association between insertion mutation in NOD2 gene and Crohn's disease in German and British populations
8. Evaluation of diagnostic criteria for ankylosing spondylitis: A proposal for modification of the New York criteria
9. A new approach to defining disease status in ankylosing spondylitis: The Bath Ankylosing Spondylitis Disease Activity Index
10. A new approach to defining functional ability in ankylosing spondylitis: The development of the Bath Ankylosing Spondylitis Functional Index
11. HLA class I associations of ankylosing spondylitis in the white population in the United Kingdom
12. Whole-genome screening in ankylosing spondylitis: Evidence of non-MHC genetic-susceptibility loci
13. Is disease severity in ankylosing spondylitis genetically determined?
14. Affected-sib-pair interval mapping and exclusion for complex genetic traits: Sampling considerations
15. Assessing the role of HLA-linked and unlinked determinants of disease
16. Recurrence risk modelling of the genetic susceptibility to ankylosing spondylitis
17. A generalization of the transmission/disequilibrium test for uncertain-haplotype transmission
18. Towards defining the genetic determinants of disease severity in ankylosing spondylitis
19. Familial versus sporadic ankylosing spondylitis: Two different diseases?
20. The prevalence of extraintestinal diseases in inflammatory bowel disease: A population-based study